W-L Listerine Anticaries Rinse Gingivitis Assessment Required - FDA
This article was originally published in The Tan Sheet
Executive Summary
Acceptance of plaque reduction as the sole outcome of an experimental gingivitis model conducted to demonstrate the antiplaque/antigingivitis activities of Pfizer/Warner-Lambert's Listerine anticaries mouthrinse would be "premature," FDA tells company.